Fig. 4From: Different effects of SGLT2 inhibitors according to the presence and types of heart failure in type 2 diabetic patientsChanges in NT-proBNP levels by SGLT2i according to the presence and types of HF. The changes in the levels of NT-proBNP were compared according to the use of SGLT2i and the presence of HF (a), and the types of HF (b). Abbreviations: as in Figs. 1 and 2Back to article page